Executive summary. Returning an uncollected prescription to stock requires the physical medication, the patient communication, and the claim record to move together.
Definition
Return to stock is the documented process of returning an eligible prepared medication to usable inventory when it is not collected.
Where this work lives in Attergo
The Attergo home view, with the Margin, Inventory, Billing, Authorization, and Compliance workspaces behind it, keeps follow-up visible across the day. Work in the screen that owns the task, assign the next action, and leave an item open until the operational question behind it is answered.
Not every prepared medication can return to stock safely. Product handling, packaging, stability, controlled-substance requirements, and organizational policy all bear on it, and the pharmacist should lead any decision affecting suitability.
Review and follow up
Use one consistent sequence for patient notification, claim reversal where applicable, physical return, and inventory update. Record exceptions separately, so an unresolved claim or an inventory difference never disappears into a completed step.
Final decisions stay with the role your organization holds accountable for them. Record the decision on the item, with the evidence behind it, so the next person to open it does not start over.
Frequently asked questions
Who should use this Attergo workspace?
The role that owns the next action leads it: a billing specialist, an authorization coordinator, an inventory lead, a pharmacist, a compliance lead, or a finance reviewer. Access follows the role your organization assigns.
Referenced standards and further reading
- USP: Compounding standards overview ↗United States Pharmacopeia
Related articles
Model dispensing as a sequence of events →
Work queues need ownership and exit criteria →
Return-to-stock controls span access, claims, and inventory →